Matches in Nanopublications for { ?s ?p "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP237940.RAV06lcjT0qVmqbcsEB2sjaSnSYsJcFoGKsHeF-A_W8mU130_provenance.
- NP306796.RA3dojCWarRpmz_CfnzBVadIBxFoOWG0kncrGKUp7KNvI130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306796.RA3dojCWarRpmz_CfnzBVadIBxFoOWG0kncrGKUp7KNvI130_provenance.
- assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP372722.RAXv7YMRQF9Fp7Ip2XQBe-VJa7gziv2MBW2_zM5fSebPQ130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372722.RAXv7YMRQF9Fp7Ip2XQBe-VJa7gziv2MBW2_zM5fSebPQ130_provenance.
- NP372724.RAYb4jkTIk28N0y8-yEpmBpLnJAOuKeA3FvJAPsaJRogo130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372724.RAYb4jkTIk28N0y8-yEpmBpLnJAOuKeA3FvJAPsaJRogo130_provenance.
- NP372728.RAuFn0kfF_xWGqw-62TtI_wH3mH3-xFfvJzA0qIhxlYPE130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372728.RAuFn0kfF_xWGqw-62TtI_wH3mH3-xFfvJzA0qIhxlYPE130_provenance.
- NP629038.RAP8UCqwu1PNuv7OYvDa3CA_ekDCw3jFOiMdSEkswbwmY130_assertion description "[Tumor tissues from 71 patients with CRC were assayed to determine the antigen levels of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor-1 and -2 (PAI-1 and PAI-2), as well as immunohistochemical expression of VEGF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629038.RAP8UCqwu1PNuv7OYvDa3CA_ekDCw3jFOiMdSEkswbwmY130_provenance.